Precision Medicine Paradigms in Allergic Rhinitis: Navigating Immunotherapy and Digital Healthcare

References

• Wang X, Du K, She W, et al. Recent advances in the diagnosis of allergic rhinitis. Expert Rev Clin Immunol. 2018;14(11):957–964. doi: 10.1080/1744666X.2018.1530113
   PubMed Web of Science ®Google Scholar
• Proper SP, Azouz NP, Mersha TB. Mersha TBJFiI. Achieving precision medicine in allergic disease: progress and challenges. Front Immunol. 2021;12:720746. doi: 10.3389/fimmu.2021.720746
   PubMed Web of Science ®Google Scholar
• Council NR, Earth Do, Studies L, et al. Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. 2011.
   Google Scholar
• Rubin MAJN. Health: make precision medicine work for cancer care. Nature. 2015;520(7547):290–291. doi: 10.1038/520290a
   PubMed Web of Science ®Google Scholar
• Khoury MJ, Iademarco MF, WTJAjopm R. Precision public health for the era of precision medicine. 2016;50(3):398. doi: 10.1016/j.amepre.2015.08.031
   Google Scholar
• Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001;344(11):783–792. doi: 10.1056/NEJM200103153441101
   PubMed Web of Science ®Google Scholar
• Flory JH, Sleiman PM, Christie JD, et al. 17q12-21 variants interact with smoke exposure as a risk factor for pediatric asthma but are equally associated with early-onset versus late-onset asthma in North Americans of European ancestry. J Allergy Clin Immunol. 2009;124(3):605–607. doi: 10.1016/j.jaci.2009.05.047
   PubMed Web of Science ®Google Scholar
• Beccia F, Causio FA, Hoxhaj I, et al. Integrating China in the international consortium for personalised medicine. A position paper on healthcare professionals’ education and citizens’ empowerment in personalised medicine. 2023;23(1):438. doi: 10.1186/s12909-023-04420-z
   Google Scholar
• König IR, Fuchs O, Hansen G, et al. What is precision medicine? Eur Respir J. 2017;50(4):1700391. doi: 10.1183/13993003.00391-2017
   PubMed Web of Science ®Google Scholar
• Montella S, Baraldi E, Cazzato S, et al. Severe asthma features in children: a case–control online survey. Ital J Pediatr. 2016;42(1):1–9. doi: 10.1186/s13052-016-0217-z
   PubMedGoogle Scholar
• von Mutius E. von Mutius EJJoa, immunology c. Influences in allergy: epidemiology and the environment. 2004;113(3):373–379. doi: 10.1016/j.jaci.2003.12.040
   Google Scholar
• Wise SK, Damask C, Roland LT, et al., editors. International consensus statement on allergy and rhinology: allergic rhinitis–2023. In International forum of allergy & rhinology. Wiley Online Library; 2023.
   Google Scholar
• Bauchau V, Sjerj D. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24(5):758–764. doi: 10.1183/09031936.04.00013904
   PubMed Web of Science ®Google Scholar
• Licari A, Caimmi S, Bosa L, et al. Rhinosinusitis and asthma: a very long engagement. Int J Immunopathol Pharmacol. 2014;27(4):499–508. doi: 10.1177/039463201402700405
   PubMed Web of Science ®Google Scholar
• Bousquet J, Pfaar O, Agache I, et al. ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy. 2021;11(4):e12014.
   Google Scholar
• Cirillo I, Marseglia G, Klersy C, et al. Allergic patients have more numerous and prolonged respiratory infections than nonallergic subjects. Allergy. 2007;62(9):1087–1090. doi: 10.1111/j.1398-9995.2007.01401.x
   PubMed Web of Science ®Google Scholar
• Brambilla I, Pusateri A, Pagella F, et al. Adenoids in children: advances in immunology, diagnosis, and surgery. 2014;27(3):346–352. doi: 10.1002/ca.22373
   Google Scholar
• Marseglia GL, Pagella F, Klersy C, et al. The 10-day mark is a good way to diagnose not only acute rhinosinusitis but also adenoiditis, as confirmed by endoscopy. 2007;71(4):581–583. doi: 10.1016/j.ijporl.2006.12.003
   Google Scholar
• Hoyte FC, Hsjf N. Recent advances in allergic rhinitis. F1000Res. 2018;7:1333. doi: 10.12688/f1000research.15367.1
   Google Scholar
• Ortiz RA, Kcji B, Clinics A. Genetics of allergic diseases. Immunol Allergy Clin North Am. 2015;35(1):19–44. doi: 10.1016/j.iac.2014.09.014
   PubMed Web of Science ®Google Scholar
• Qin Z, Xie L, Li W, et al. New Insights into Mechanisms Traditional Chinese Medicine for Allergic Rhinitis by Regulating Inflammatory and Oxidative Stress Pathways. J Asthma Allergy. 2024;Volume 17:97–112. doi: 10.2147/JAA.S444923
   Web of Science ®Google Scholar
• Watanabe K, Matsuura K, Gao P, et al. Traditional Japanese Kampo medicine: clinical research between modernity and traditional medicine—the state of research and methodological suggestions for the future. Evidence-Based Complementary Altern Med. 2011;2011(1). doi: 10.1093/ecam/neq067
   Google Scholar
• Dahanayake JM, Perera PK, Galappaththy P, et al. Efficacy and safety of two Ayurvedic dosage forms for allergic rhinitis: Study protocol for an open-label randomized controlled trial. Trials. 2020;21(1):1–8. doi: 10.1186/s13063-019-4004-1
   PubMedGoogle Scholar
• Mahomoodally MFJE-bc, medicine a. Traditional medicines in Africa: an appraisal of ten potent African medicinal plants. 2013;
   Google Scholar
• Rasool R, Shera IA, Nissar S, et al. Role of skin prick test in allergic disorders: a prospective study in kashmiri population in light of review. 2013;58(1):12–17. doi: 10.4103/0019-5154.105276
   Google Scholar
• Ansotegui IJ, Melioli G, Canonica GW, et al. IgE allergy diagnostics and other relevant tests in allergy. World Allergy Organ Position Pap. 2020;13(2):100080. doi: 10.1016/j.waojou.2019.100080
   PubMed Web of Science ®Google Scholar
• Agache I, Bilò M, Braunstahl GJ, et al. In vivo diagnosis of allergic diseases-allergen provocation tests. Allergy. 2015;70(4):355–365. doi: 10.1111/all.12586
   PubMed Web of Science ®Google Scholar
• González-Pérez R, El-Qutob D, Letrán A, et al. Precision medicine in mite allergic rhinitis Front. Allergy. 2021;2:724727. doi: 10.3389/falgy.2021.724727
   Google Scholar
• Angjeli E, Gomes P, Lane KJ, et al. Technical and clinical validation of the Allergen BioCube® for Timothy grass. 2017;5(1):78–84. doi: 10.1002/iid3.143
   Google Scholar
• Jeon H, Jung JH, Kim Y, et al. Allergen microarrays for in vitro diagnostics of allergies: comparison with ImmunoCAP and AdvanSure. 2018;38(4):338. doi: 10.3343/alm.2018.38.4.338
   Google Scholar
• Anto JM, Bousquet J, Akdis M, et al. Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes. 2017;139(2):388–399. doi: 10.1016/j.jaci.2016.12.940
   Google Scholar
• Hoffmann H, Santos A, Mayorga C, et al. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. 2015;70(11):1393–1405. doi: 10.1111/all.12698
   Google Scholar
• Bousquet J, Pfaar O, Togias A, et al. 2019 ARIA Care pathways for allergen immunotherapy. Alergologia 2019;4(3):2087–2102. doi: 10.26416/Aler.3.4.2019.2749
   Google Scholar
• Allen K, Canonica GW, Ansotegui IJ, et al. A WAO-ARIA-GA2LEN consensus document on molecular-based allergy diagnostics. 2013;6(1).
   Google Scholar
• Matricardi P, Kleine‐Tebbe J, Hoffmann H, et al. EAACI molecular allergology user’s guide. 2016;27:1–250. doi: 10.1111/pai.12563
   Google Scholar
• Luengo O, Cardona VJC, allergy t. Component resolved diagnosis: when should it be used? Clin Transl Allergy. 2014;4(1):1–9. doi: 10.1186/2045-7022-4-28
   PubMedGoogle Scholar
• Barber D, Moreno C, Ledesma A, et al. Degree of olive pollen exposure and sensitization patterns. Clin Implic. 2007;17(Suppl 1):11–16.
   Google Scholar
• Douladiris N, Savvatianos S, Roumpedaki I, et al. A molecular diagnostic algorithm to guide pollen immunotherapy in southern Europe: towards component-resolved management of allergic diseases. 2013;162(2):163–172. doi: 10.1159/000353113
   Google Scholar
• Kucuksezer UC, Ozdemir C, Cevhertas L, et al. Mechanisms of allergen-specific immunotherapy and allergen tolerance. 2020;69(4):549–560. doi: 10.1016/j.alit.2020.08.002
   Google Scholar
• Johnson L, Duschl A, Himly MJV. Nanotechnology-based vaccines for allergen-specific immunotherapy: Potentials and challenges of conventional and novel adjuvants under research. 2020;8(2):237. doi: 10.3390/vaccines8020237
   Google Scholar
• Tsabouri S, Tseretopoulou X, Priftis K, et al. Omalizumab for the treatment of inadequately controlled allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials. J Allergy Clin Immunol Pract. 2014;2(3):332–340. e1. doi: 10.1016/j.jaip.2014.02.001
   PubMed Web of Science ®Google Scholar
• Tsetsos N, Goudakos JK, Daskalakis D, et al. Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review. 2018;56(1):11–21. doi: 10.4193/Rhin17.156
   Google Scholar
• Khwaja S, Kumar B, Philpott C, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. 2019.
   Google Scholar
• Ghadersohi STan BKJOCoNA. Contemporary pharmacotherapy for allergic rhinitis and chronic rhinosinusitis. Otolaryngol Clin North Am. 2017;50(6):1135–1151. doi: 10.1016/j.otc.2017.08.009
   PubMed Web of Science ®Google Scholar
• Oakley GM, Harvey RJ, VJJCa L, et al. The role of macrolides in chronic rhinosinusitis (CRSsNP and CRSwNP). Curr Allergy Asthma Rep. 2017;17(5):1–10. doi: 10.1007/s11882-017-0696-z
   PubMed Web of Science ®Google Scholar
• Hellings PW, Klimek L, Cingi C, et al. Non‐allergic rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. 2017;72(11):1657–1665. doi: 10.1111/all.13200
   Google Scholar
• Klimek L, Dollner R, Pfaar O, et al. Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)? Curr Allergy Asthma Rep. 2014;14(6):1–9. doi: 10.1007/s11882-014-0441-9
   Web of Science ®Google Scholar
• Malmberg H, Grahne B, Holopainen E, et al. Ipratropium (Atrovent) in the treatment of vasomotor rhinitis of elderly patients. 1983;8(4):273–276. doi: 10.1111/j.1365-2273.1983.tb01441.x
   Google Scholar
• Van Gerven L, Steelant B, Hellings PJA. Nasal hyperreactivity in rhinitis: A diagnostic and therapeutic challenge. 2018;73(9):1784–1791. doi: 10.1111/all.13453
   Google Scholar
• Agache I, CAJTJoci A. Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases. J Clin Investigation. 2019;129(4):1493–1503. doi: 10.1172/JCI124611
   PubMed Web of Science ®Google Scholar
• Shiraishi Y, Takeda K, Domenico J, et al. Role of prostaglandin D2 and CRTH2 blockade in early- and late-phase nasal responses. Clin Exp Allergy. 2014;44(8):1076–1082. doi: 10.1111/cea.12280
   PubMed Web of Science ®Google Scholar
• Krug N, Gupta A, Badorrek P, et al. Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis. J Allergy Clin Immunol. 2014;133(2):414–419. e8. doi: 10.1016/j.jaci.2013.10.013
   PubMed Web of Science ®Google Scholar
• Ratner P, Andrews CP, Hampel FC, et al. Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo-and active-referenced studies. Allergy, Asthma & Clin Immunol. 2017;13(1):1–15. doi: 10.1186/s13223-017-0183-z
   Google Scholar
• Voukantsis D, Berger U, Tzima F, et al. Personalized symptoms forecasting for pollen-induced allergic rhinitis sufferers. Int J Biometeorol. 2015;59(7):889–897. doi: 10.1007/s00484-014-0905-6
   PubMed Web of Science ®Google Scholar
• Meurs H, Zaagsma J, Maarsingh H, et al. Recent patents in allergy/immunology: use of arginase inhibitors in the treatment of asthma and allergic rhinitis. 2019;74(6):1206. doi: 10.1111/all.13770
   Google Scholar
• Liu AH, Anderson WC III, Dutmer CM, et al. Advances in asthma 2015: Across the lifespan. 2016;138(2):397–404. doi: 10.1016/j.jaci.2016.06.013
   Google Scholar
• Brockow KJA. Dilemmas of allergy diagnosis in perioperative anaphylaxis. 2014;69(10):1265–1266. doi: 10.1111/all.12485
   Google Scholar
• Vidal C, Porras-Hurtado L, Cruz R, et al. Association of thromboxane A1 synthase (TBXAS1) gene polymorphism with acute urticaria induced by nonsteroidal anti-inflammatory drugs. 2013;132(4):989–991. doi: 10.1016/j.jaci.2013.04.045
   Google Scholar
• Khan DA, EjjjoA P, Immunology C. Pharmacogenomic biomarkers in allergy and immunology practice. J Allergy Clin Immunol. 2020;146(3):509–512. doi: 10.1016/j.jaci.2020.05.050
   PubMed Web of Science ®Google Scholar
• Murrison LB, Brandt EB, Myers JB, et al. Environmental exposures and mechanisms in allergy and asthma development. 2019;129(4):1504–1515. doi: 10.1172/JCI124612
   Google Scholar
• Bousquet J, Devillier P, Arnavielhe S, et al. Treatment of allergic rhinitis using mobile technology with real‐world data: the MASK observational pilot study. 2018;73(9):1763–1774. doi: 10.1111/all.13406
   Google Scholar
• Munteanu LA, Frandes M, Timar B, et al. The efficacy of a mobile phone application to improve adherence to treatment and self-management in people with chronic respiratory disease in Romanian population–a pilot study. BMC Health Serv Res. 2020;20(1):1–11. doi: 10.1186/s12913-020-05340-0
   Web of Science ®Google Scholar
• Nebeker C, Parrish EM, Graham S. The AI-powered digital health sector: ethical and regulatory considerations when developing digital mental health tools for the older adult demographic. In: Artificial Intelligence in Brain and Mental Health: Philosophical, Ethical & Policy Issues. Springer; 2022. p. 159–176.
   Google Scholar
• Breiteneder H, Diamant Z, Eiwegger T, et al. Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care. 2019;74(12):2293–2311. doi: 10.1111/all.13851
   Google Scholar
• Licari A, Castagnoli R, Tosca MA, et al. Personalized therapies for the treatment of allergic rhinitis. 2019;4(5):275–281. doi: 10.1080/23808993.2019.1681896
   Google Scholar
• Zhang Y, Lan F, Zhang LJA. Advances and highlights in allergic rhinitis. 2021;76(11):3383–3389. doi: 10.1111/all.15044
   Google Scholar
• Li H, Chen S, Cheng L, et al. Chinese guideline on sublingual immunotherapy for allergic rhinitis and asthma. 2019;11(12):4936.
   Google Scholar
• Dhami S, Nurmatov U, Arasi S, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta‐analysis. 2017;72(11):1597–1631. doi: 10.1111/all.13201
   Google Scholar
• Rudin RS, Fischer SH, Y SHI, et al. Trends in the use of clinical decision support by health system–affiliated ambulatory clinics in the united states. 2019;7(4):4–10.
   Google Scholar
• Sutton RT, Pincock D, Baumgart DC, et al. An overview of clinical decision support systems: benefits, risks, and strategies for success. 2020;3(1):17. doi: 10.1038/s41746-020-0221-y
   Google Scholar
• Prgomet M, Li L, Niazkhani Z, et al. Impact of commercial computerized provider order entry (CPOE) and clinical decision support systems (CDSSs) on medication errors, length of stay, and mortality in intensive care units: a systematic review and meta-analysis. 2017;24(2):413–422. doi: 10.1093/jamia/ocw145
   Google Scholar
• Dramburg S, Marchante Fernández M, Potapova E, et al. The potential of clinical decision support systems for prevention, diagnosis, and monitoring of allergic diseases. 2020;11:575892. doi: 10.3389/fimmu.2020.02116
   Google Scholar
• Costa C, Menesatti P, Brighetti M, et al. Pilot study on the short-term prediction of symptoms in children with hay fever monitored with e-Health technology. Eur Ann Allergy Clin Immunol. 2014;46(6):216–225.
   PubMedGoogle Scholar
• Matricardi PM, Dramburg S, Alvarez‐Perea A, et al. The role of mobile health technologies in allergy care: An EAACI position paper. 2020;75(2):259–272. doi: 10.1111/all.13953
   Google Scholar
• Correia de Sousa J. ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. 2016.
   Google Scholar
• Ridolo E, Incorvaia C, Pucciarini F, et al. Current treatment strategies for seasonal allergic rhinitis: where are we heading? 2022;20(1):9. doi: 10.1186/s12948-022-00176-x
   Google Scholar
• Shamji MH, Valenta R, Jardetzky T, et al. The role of allergen‐specific IgE, IgG and IgA in allergic disease. 2021;76(12):3627–3641. doi: 10.1111/all.14908
   Google Scholar
• Kauppinen Z, Rautiainen T, Mäntyjärvi V, et al. Mutant derivatives of the main respiratory allergen of cow are less allergenic than the intact molecule. Clin & Exp Allergy. 1999;29(7):989–996. doi: 10.1046/j.1365-2222.1999.00605.x
   PubMed Web of Science ®Google Scholar
• Shen L, Kapsogeorgou EK, Yu M, et al. Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary Sjogren’s syndrome. 2014;155(1):42–46. doi: 10.1016/j.clim.2014.08.009
   Google Scholar
• Yen C-Y, Yu C-H, Tsai J-J, et al. Effects of local nasal immunotherapy with FIP-fve peptide and denatured Tyrophagus putrescentiae for storage mite-induced airway inflammation. 2022;70(1):6. doi: 10.1007/s00005-022-00645-w
   Google Scholar
• Kasemsuk N, Ngaotepprutaram P, Kanjanawasee D, et al., editors. Local nasal immunotherapy for allergic rhinitis: a systematic review and meta‐analysis. In International Forum of Allergy & Rhinology. Wiley Online Library; 2022.
   Google Scholar
• Ridolo E, Incorvaia C, Heffler E, et al. The present and future of allergen immunotherapy in personalized medicine. 2022;12(5):774.
   Google Scholar
• Dhami S, Kakourou A, Asamoah F, et al. Allergen immunotherapy for allergic asthma: a systematic review and meta‐analysis. 2017;72(12):1825–1848. doi: 10.1111/all.13208
   Google Scholar
• Larenas‐Linnemann D, Antolín‐Amérigo D, Parisi C, et al. National clinical practice guidelines for allergen immunotherapy: an international assessment applying AGREE‐II. 2018;73(3):664–672. doi: 10.1111/all.13316
   Google Scholar
• Huang Y, Wang C, Wang X, et al. Efficacy and safety of subcutaneous immunotherapy with house dust mite for allergic rhinitis: a meta‐analysis of randomized controlled trials. 2019;74(1):189–192. doi: 10.1111/all.13583
   Google Scholar
• Jarkvist J, Salehi C, Akin C, et al. Venom immunotherapy in patients with clonal mast cell disorders: IgG4 correlates with protection. 2020;75(1):169–177. doi: 10.1111/all.13980
   Google Scholar
• Tam H, Calderon MA, Manikam L, et al. Specific allergen immunotherapy for the treatment of atopic eczema. Database Systematic Rev. 2016 2;2016(2). doi: 10.1002/14651858.CD008774.pub2
   Google Scholar
• Reier‐Nilsen T, Michelsen MM, Lødrup Carlsen KC, et al. Feasibility of desensitizing children highly allergic to peanut by high‐dose oral immunotherapy. 2019;74(2):337–348. doi: 10.1111/all.13604
   Google Scholar
• Chu DK, Wood RA, French S, et al. Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety. 2019;393(10187):2222–2232. doi: 10.1016/S0140-6736(19)30420-9
   Google Scholar
• Senti G, Freiburghaus AU, Larenas-Linnemann D, et al. Intralymphatic immunotherapy: update and unmet needs. 2019;178(2):141–149. doi: 10.1159/000493647
   Google Scholar
• Witten M, Malling H-J, Blom L, et al. Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy? J Allergy And Clin Immunol. 2013;132(5):1248–1252. e5. doi: 10.1016/j.jaci.2013.07.033
   PubMed Web of Science ®Google Scholar
• Jones SM, Sicherer SH, Burks AW, et al. Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults. J Allergy Clin Immunol. 2017;139(4):1242–1252. e9. doi: 10.1016/j.jaci.2016.08.017
   PubMed Web of Science ®Google Scholar
• Pongracic JA, Gagnon R, Sussman G, et al. Safety of epicutaneous immunotherapy in peanut-allergic children: REALISE randomized clinical trial results. J Allergy Clin Immunol Pract. 2022;10(7):1864–1873. e10. doi: 10.1016/j.jaip.2021.11.017
   PubMed Web of Science ®Google Scholar
• Mondoulet L, Dioszeghy V, Busato F, et al. Gata3 hypermethylation and Foxp3 hypomethylation are associated with sustained protection and bystander effect following epicutaneous immunotherapy in peanut‐sensitized mice. 2019;74(1):152–164. doi: 10.1111/all.13479
   Google Scholar
• Spergel JM, Elci OU, Muir AB, et al. Efficacy of epicutaneous immunotherapy in children with milk-induced eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2020;18(2):328–336. e7. doi: 10.1016/j.cgh.2019.05.014
   PubMed Web of Science ®Google Scholar
• Jeny F, Uzunhan Y, Lacroix M, et al. Predictors of mortality in fibrosing pulmonary sarcoidosis. 2020;169:105997. doi: 10.1016/j.rmed.2020.105997
   Google Scholar
• Fricke-Galindo I, Ortega-Vázquez A, Monroy-Jaramillo N, et al. Allele and genotype frequencies of genes relevant to anti-epileptic drug therapy in Mexican-Mestizo healthy volunteers. 2016;17(17):1913–1930.
   Google Scholar
• AJIrop G. Complexities of CYP2D6 gene analysis and interpretation. Int Rev Psychiatry. 2013;25(5):534–553. doi: 10.3109/09540261.2013.825581
   PubMed Web of Science ®Google Scholar
• Sim S, Kacevska M, Ingelman-Sundberg MJTpj. Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects. Pharmacogenomics J. 2013;13(1):1–11. doi: 10.1038/tpj.2012.45
   PubMed Web of Science ®Google Scholar